期刊文献+

缺血性卒中患者服用阿司匹林后再发脑梗死的危险因素分析 被引量:7

Analysis of risk factors of ischemic stroke recurrence of ischemic stroke patients using aspirin
下载PDF
导出
摘要 目的探讨缺血性卒中患者服用阿司匹林进行二级预防后再发脑梗死的危险因素。方法收集我院缺血性卒中265例患者的资料:年龄、性别、高血压病、冠心病、糖尿病、高脂血症、高同型半胱氨酸血症病史、吸烟史等情况,并对在服药期间患者各项卒中危险因素的控制情况进行随访:包括血压、血脂、血糖、同型半胱氨酸水平,并依据调查结果筛选出水平高于正常的患者。随访3年,患者分为缺血性卒中再发组和缺血性卒中无再发组两组,分析以上因素在两组间的差异。结果 265例患者入选,5例因其他系统疾病死亡失访,8例因出现胃肠道并发症停用阿司匹林,252例参加随访的缺血性卒中病例中54例再发,再发率21.4%。单因素分析显示,缺血性卒中再发组中合并高脂血症、糖尿病或高同型半胱氨酸血症的患者比例显著高于缺血性卒中无再发组;缺血性再发组在服用阿司匹林期间血浆总胆固醇(TC)及低密度脂蛋白(LDL)水平高于正常或血脂3项都高于正常、血糖水平高于正常、同型半胱氨酸(Hcy)水平高于正常的患者比例明显高于缺血性卒中无再发组。多因素分析显示,服用阿司匹林期间,TC及LDL高于正常或血脂3项都高于正常[比值比(odds ratio,OR)=2.54;95%置信区间(confidenceinterval,C I)1.33~5.36,P=0.007]、血糖水平高于正常(OR=2.83;95%C I 1.49~5.61,P=0.003)、血浆HCY水平高于正常(OR=2.44;95%C I 1.29~5.28,P=0.009)与服用阿司匹林进行缺血性卒中二级预防患者的脑梗死再发独立相关。结论服用阿司匹林期间,TC及LDL高于正常或血脂3项都高于正常、空腹血糖水平高于正常以及同型半胱氨酸水平高于正常是服用阿司匹林预防进行二级预防患者缺血性卒中再发的独立危险因素。 Objective To investigate the risk factors of ischemic stroke recurrence of ischemic stroke patients using aspirin.Methods Data of 265 ischemic stroke patients using aspirin in our hospital were collected.Age,sex,history of hypertension,coronary disease,diabetes,hyperlipidemia,hyperhomocysteinemia and smoking were recorded.Levels of blood pressure,blood-fat,blood sugar and homocysteine during aspirin using were followed up and patients with higher levels were selected.We followed up the patients for 3 years.Patients were divided into 2 groups,ischemic recurrence group and non-recurrence group.We analyzed the difference of risk factors between 2 groups.Results Two hundred and sixty-five cases were included in the present study.5 of them died of other system diseases and 8 of them suspended using aspirin because of gastrointestinal complication.54 of 252 patients(21.4%)had ischemic stroke recurrence.Single factor analysis showed that history of diabetes,hyperlipidemia or hyperhomocysteinemia were more frequent in ischemic recurrence group.The rate of patients with high level of TC and LDL(or TC,LDL and TG),blood sugar or Hcy than normal in ischemic recurrence group was higher than that in non-ischemic recurrence group.Logistic regression analysis showed that during the period that patients using aspirin,level of TC and LDL(or TC,LDL and TG)was higher than normal(OR=2.54;95%CI=1.33~5.36,P=0.007),level of blood sugar was higher than normal(OR=2.83;95%CI=1.49~5.61,P=0.003),and level of Hcy was higher than normal(OR=2.44;95%CI=1.29~5.28,P=0.009).They were the independent risk factors of ischemic stroke recurrence for ischemic stroke patients using aspirin.Conclusion On medication of aspirin,higher level of TC and LDL(or TC,LDL and TG),higher level of blood sugar and higher level of Hcy are the independent risk factors of ischemic stroke recurrence for patients using aspirin for the secondary prevention of stroke.
作者 谭杰 李承晏
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2011年第5期437-440,共4页 Journal of Apoplexy and Nervous Diseases
关键词 缺血性卒中 低密度脂蛋白 总胆固醇 高血糖 同型半胱氨酸 Ischemic stroke Low density lipoprotein Total cholesterol Hyperglycemia Homocysteine
  • 相关文献

参考文献19

  • 1Antithrombotic Trialists" s Collaboration. Collaboration meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction,and stroke in high risk patients[J]. BMJ,2002, 324(7329) :71 -86.
  • 2Patrono C, Coller B, Fitz Gerald GA, et al. Platelet active drugs: the relationships among dose, effectiveness, and side effects [ J ]. Chest, 2004,126( Suppl 3) :234 -264.
  • 3规范应用阿司匹林治疗缺血性脑血管病的专家共识[J].中华内科杂志,2006,45(1):81-82. 被引量:76
  • 4Sacco RL, Adams R, Albers G, et aL Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemie attaek:a statement for heahhcare professionals from the American Heart Associ- ation/American Stroke Association Council on Stroke:co-sponsored by the Council on Cardiovascular Radiology and Intervention:the American Academy of Neurology affirms the value of this guideline [ J ]. Stroke,2006,37 (2) :577 - 617.
  • 5CAST ( Chinese Acute Stroke Trial ) Collaborative Group. CAST : randomized placebo-controlled trial of early aspirin use in 20000 patients with acute ischaemic stroke [ J ]. Lancet, 1997,349 ( 9066 ) : 1641 - 1649.
  • 6International Stroke Trial Collaborative Group. IST : a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemie stroke [ J ]. Lancet, 1997,349 ( 9065 ) : 1569 - 1581.
  • 7Sivenius J, Cunha L, Diener HC, et al. Second European Stroke prevention Study : antiplatelet therapy is effective regardless of age. ESPS Working Group [ J ]. Acta Neurol Scand, 1999,99 ( 1 ) :54 - 60.
  • 8Hankey GJ,Eikeboom JW. Aspirin resistance [J]. Lancet,2006,367 (9510) :606 -617.
  • 9Saceo RL,Benson RT,Kargman DE. High-density lipoprotein cholesterol and ischenfic stroke in the elderly:the Northern Manhattan Stroke Study[ J ]. JAMA ,2001,285 (21) :2729 - 2735.
  • 10Alnareneo P,Elbaza A. On behalf of the GENIC investigators. Hypercholesterolemia as a risk factor for brain infarction: case control study from GENIC [ J ]. Cerebrovascular Dis, 1998,231 (59) :82.

二级参考文献7

  • 1Antithrombotic Trialists′ Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients.BMJ,2002,324:71-86.
  • 2Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events.The SALT Collaborative Group.Lancet,1991,338:1345-1349.
  • 3European Stroke Prevention Study 2.Efficacy and safety data.J Neurol Sci,1997,151 Suppl:S1-S77.
  • 4Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke.EAFT (European Atrial Fibrillation Trial) Study Group.Lancet,1993,342:1255-1262.
  • 5Ridker PM,Cook NR,Lee IM,et al.A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.N Engl J Med,2005,352:1293-1304.
  • 6The International Stroke Trial (IST):a randomised trial of aspirin,subcutaneous heparin,both,or neither among 19435 patients with acute ischaemic stroke.International Stroke Trial Collaborative Group.Lancet,1997,349:1569-1581.
  • 7CAST:randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke.CAST (Chinese Acute Stroke Trial) Collaborative Group.Lancet,1997,349:1641-1649.

共引文献75

同被引文献44

  • 1陈少媚,李勇,谢坚.阿司匹林联合氯吡格雷对阿司匹林抵抗患者预防缺血性脑卒中的疗效评价[J].中国现代医药杂志,2010(7):66-68. 被引量:8
  • 2李洁,刘妍君.缺血性脑卒中并脑微出血的相关因素分析[J].中国动脉硬化杂志,2015,23(2):180-184. 被引量:19
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33058
  • 4Chien KL, Hsu HC, Su TC, et al. Lipoprotein (a) and cardio- vascular disease in ethnic Chinese:the Chin-Shan Community Cardiovascular Cohort study [ J ]. Clin Chem, 2008,54 ( 2 ) : 285-291.
  • 5Nagy JB, Miszti BK,Kerenyi A,et al. Potential therapeutic tar- geting of platelet mediated cellular interactions in atherosclero- sis and inflammation~ J~. Curr Med Chem, 2012,19 (4) :518- 531.
  • 6Messner B, Bernhard D.Smoking and cardiovascular disease:mechanisms of endothelial dysfunction and early atherogenesis[J]. Arterioscler Thromb Vase Biol,2014,34(3) :509-515.
  • 7Hart RG,Pearce LA,Bakheet MF, et al .Predictors of strokerecurrence in patients with recent lacunar stroke and responseto interventions according to risk status : secondary preventionof small subcortical strokes trial [J], J Stroke CerebrovascDis, 2014,23(4):618-624.
  • 8Toni D. Types of stroke recurrence in patients with ischemicstroke: a substudy from the PRoFESS trial[J]. Int J Stroke,2014,9(7):873-878.
  • 9Huang J,Liu B,Yang C, et al .Acute hyperglycemia worsensischemic stroke-induced brain damage via high mobility groupbox-1 in rats[JD. Brain Res,2013.1535 : 148-155.
  • 10Messner B,Bernhard D.Smoking and cardiovascular disease:mechanisms of endothelial dysfunction and early atherogenesis[J].Arterioscler Thromb Vase Biol,2014,34(3):509-515.

引证文献7

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部